The Transcription Factor Zeb2 Regulates Signaling in Mast Cells

Mast cell activation results in the release of stored and newly synthesized inflammatory mediators. We found that Zeb2 (also named Sip1, Zfhx1b), a zinc finger transcription factor, regulates both early and late mast cell responses. Transfection with small interfering RNA (siRNA) reduced Zeb2 expression and resulted in decreased Fc epsilon RI-mediated degranulation, with a parallel reduction in receptor-induced activation of NFAT and NF-kappa B transcription factors, but an enhanced response to the LPS-mediated activation of NF-kappa B. There was variable and less of a decrease in the Ag-mediated release of the cytokines TNF-alpha, IL-13, and CCL-4. This suggests that low Zeb2 expression differentially regulates signaling pathways in mast cells. Multiple phosphorylation events were impaired that affected molecules both at early and late events in the signaling pathway. The Zeb2 siRNA-treated mast cells had altered cell cycle progression, as well as decreased expression of several molecules including cell surface Fc epsilon RI and its beta subunit, Gab2, phospholipase-C gamma 1, and phospholipase-C gamma 2, all of which are required for receptor-induced signal transduction. The results indicate that the transcription factor Zeb2 controls the expression of molecules thereby regulating signaling in mast cells. The Journal of Immunology, 2012, 188: 6278-6286.